National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2011 (No. 9) (No. PB 69 of 2011)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Get a Day Pass for only USD$49.99.
 
PB 69 of 2011
National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2011 (No. 9)
 
National Health Act 1953
___________________________________________________________________________
 
 
I, KIM BESSELL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated  22  September 2011
 
 
 
 
 
 
 
 
 
 
 
KIM BESSELL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
___________________________________________________________________________
 
 
 
 
1              Name of Instrument
 
(1)                This Instrument is the National Health (Highly specialised drugs program for hospitals) Special Arrangement Amendment Instrument 2011 (No.9).
 
(2)                This Instrument may also be cited as PB 69 of 2011.
 
2             Commencement
                             This Instrument commences on 1 October 2011.
3              Amendments to PB 116 of 2010
                Schedule 1 amends the National Health (Highly specialised drugs program for hospitals) Special Arrangement 2010 (PB 116 of 2010)
.
 
 
Schedule 1                   Amendments
 
[1]    Schedule 1, entry for Iloprost, in the column ‘Responsible Person’
substitute:
         BN
 
[2]    Schedule 1, entry for Ribavirin and Peginterferon Alfa-2b
substitute:

Ribavirin and Peginterferon Alfa-2b
Pack containing 112 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 50 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 84 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 80 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 80 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 112 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 100 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 120 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 140 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 168 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
Pack containing 196 capsules ribavirin 200 mg and 4 single use injection pens containing peginterferon alfa-2b powder for injection 150 micrograms with diluent
Injection/oral
Pegatron
MK
EMP
C3053 C3055 C3413 C3414
 
2
5
D

 
[3]    Schedule 2, Responsible Person Codes
omit:
SC
Bayer Australia Ltd
 22 000 138 714
 
[4]    Schedule 2, Responsible Person Codes
Insert in alphabetical order of responsible person code:
BN
Bayer Australia Ltd
 22 000 138 714
 
Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. 
See http://www.frli.gov.au.

Related Laws